Cord blood-platelet lysate (CB-PL), containing growth factors such as a platelet-derived growth factor, has a similar efficacy to peripheral blood-platelet lysate (PB-PL) in initiating cell growth and differentiation, which makes it a unique alternative to be implemented into oral ulceration healing. This research study aimed to compare the effectiveness of CB-PL and PB-PL in promoting oral wound closure in vitro. Alamar blue assay was used to determine the optimal concentration of CB-PL and PB-PL in enhancing the proliferation of human oral mucosal fibroblasts (HOMF). The percentage of wound closure was measured using the wound-healing assay for CB-PL and PB-PL at the optimal concentration of 1.25% and 0.3125%, respectively. The gene expressions of cell phenotypic makers (Col. I, Col. III, elastin and fibronectin) were determined via qRT-PCR. The concentrations of PDGF-BB were quantified using ELISA. We found that CB-PL was as effective as PB-PL in promoting wound-healing and both PL were more effective compared to the control (CTRL) group in accelerating the cell migration in the wound-healing assay. The gene expressions of Col. III and fibronectin were significantly higher in PB-PL compared to CB-PL. The PDGF-BB concentration of PB-PL was the highest and it decreased after the wound closed on day 3. Therefore, we concluded that PL from both sources can be a beneficial treatment for wound-healing, but PB-PL showed the most promising wound-healing properties in this study.
Subcutaneous emphysema (SE) is a swelling which develops due to air entrapped underneath the subcutaneous tissue and facial planes causing distention of the overlying skin. SE can develop due to trauma, surgery, or infection. The diagnosis of SE is mostly based on clinical findings of crepitation upon palpation of the swelling. Once diagnosed, SE is usually managed by close observation and in some cases may require surgical decompression and antibiotic prophylaxis. We report a rare case of SE of the left malar which developed following closure of oroantral communication using the buccal fat pad.
Background: Alveolar lymphangioma is a rare condition that commonly develops on the alveolar ridge of Black male neonates. It typically presents as a bluish, dome‐shaped swelling smaller than 1 cm on the posterior alveolar ridge of the mandible or/and maxilla, that allows it to be diagnosed clinically. Most previously reported cases of alveolar lymphangioma report spontaneous resolution, and biopsy is seldom performed unless the lesion becomes symptomatic or interferes with feeding.Case Report: We report a case of oral alveolar lymphangioma on the anterior maxillary alveolar ridge of an 11‐day‐old infant of non‐black descent. The lesion presented as a pedunculated, reddish, lobular mass in the anterior maxilla. Given its atypical presentation and the potential for feeding difficulties, an excisional biopsy was performed. The diagnosis was confirmed histologically through biopsy and supported by immunohistochemical staining.Conclusion: This case expands the understanding of alveolar lymphangioma by reporting it in a non‐Black neonate with an unusual location and appearance, emphasising the need for excisional biopsy to rule out other potential oral lesions, especially neoplasms.
5 May 2026 in Clinical and Experimental Dental Research
Objectives: There has not been a comprehensive study examining the epidemiology, clinical presentation, and histology of oral lichen planus (OLP) and oral lichenoid lesions (OLL) in New Zealand. The aim of this study was to determine the clinico‐pathologic manifestation in a New Zealand population. Methods: The study retrospectively analyzed OLP and OLL cases from the electronic database of the Oral Pathology Centre, University of Otago, that were clinically diagnosed and histologically confirmed. Their demographic, clinical, and histopathologic data were comparatively analyzed for statistical significance using Fisher's exact test and chi‐square. Results: Of all the samples received over the years 2011 to 2023, 232 were identified as OLP and 563 were identified as OLL. The patient's mean age was 45 years in OLP and 56 years in OLL, and the M:F ratio was 1:1.86 and 1:1.94, respectively. Buccal mucosa and gingiva were the most common sites involved in OLP, but in OLL, the tongue was the second most common site affected. For tongue presentation, OLP was associated with a higher frequency in the female sex, but no such sex predilection was seen in OLL, and these associations were statistically significant. The number of multiple intra‐oral anatomical sites affected was higher in the OLP groups compared to OLL. Conclusion: This is the first study to examine the relative frequency of OLP and OLL in a New Zealand population. The current data are consistent with global epidemiological data, with the exception that the female predominance was not seen for tongue OLL lesions. Accurately determining the relative frequency of OLP and OLL is crucial. This effort not only validates our current understanding of these specific lesions within the New Zealand population but also provides a robust, necessary baseline for all subsequent epidemiological and clinical studies.
Objectives: The present scoping review aims to explore and provide an overview of the current applications of cone beam computed tomography (CBCT) in the management of oral cancer. Methods: This study was conducted in accordance with the JBI Guidance for Scoping Reviews and reported following the PRISMA Extension for Scoping Reviews (PRISMA-ScR). A systematic search was performed across the following databases: PubMed, OVID, Scopus, Web of Science, and the Cochrane Library to answer the research question: “What are the current applications of CBCT in the perioperative management of patients with oral cancer?”. Results: A total of 52 studies met the inclusion criteria. Four major areas of CBCT application in oral cancer were identified: radiotherapy planning and monitoring (25 studies), assessment of bone invasion (16 studies), intraoperative surgical guidance (6 studies), and evaluation of treatment-related complications (5 studies). These findings highlight the diverse but focused use of CBCT across different stages of oral cancer management. Conclusions: CBCT is increasingly utilized in the perioperative management of oral cancer, with its application in radiotherapy planning and assessment being the most well-established. However, other uses, such as for surgical navigation and complication assessment, are still emerging, with promising evidence. Further research is needed to expand and validate these applications.